CANCER TEST
OVARIAN CANCER
SomArray Ovarian
Information
Questions
Turn Around Time:
SomArray Ovarian: 2 weeks*
* If the sample needs to be enriched to ensure successful results, we will contact you
I Choose SomArray Ovarian
SomArray Ovarian
With SomArray Ovarian we focus on the BRCA1 & BRCA2 genes, as well as an additional 10 genes that statistically show genetic instability more often in ovarian cancer.
Consult your Oncologist to get the best possible choice for you and personalized treatment. Further personalization of exams is possible.
In case your sample is not already in microDiagnostics Ltd files. Contact us to arrange safe and fast shipping to our laboratory. You will also need to complete easily and quickly a Consent Form.
The number and type of mutations that are examined are being informed through a dynamic process, according to current scientific research. It should, therefore, be recognized that there is a possibility the list of genes in the order form may have been changed (genes that are added or removed) while analyzing the sample in the laboratory
If you have been diagnosed with ovarian cancer (diagnosis based on histological examination), it is possible that the indications for determining the molecular profile of cancer will be met. This molecular test aims to detect whether the tumor has mutations in the BRCA1 and BRAC2 genes as well as in 10 other closely related genes associated with ovarian cancer
According to the NCCN (National Comprehensive Cancer Network), patients with invasive ovarian cancer (serous, non-mucosal carcinomas, high-grade malignancy) carrying mutations in the BRCA1 & BRCA2 genes seem to have improved prognosis and response in chemotherapy than patients who have been diagnosed with ovarian cancer without mutations in the BRCA1 & BRCA2 genes. More specifically, these patients show:
- higher 5-year survival rates
- higher Progression-Free Survival
- better response to chemotherapy than patients with ovarian cancer without mutations in BRCA1 & BRCA2 genes
The SomArray Prostate is conducted on the biopsy material or lumpectomy (paraffin block) on which your histology examination has been conducted.
At our vertically integrated Laboratory, we handle your sample in such a way as to minimize its unnecessary waste:
- The paraffin block is inserted if it is possible once in the microtome to obtain tissue incisions by experienced histotechnologists.
- Tissue sections are sequentially acquired in such a way as to provide immunohistochemical stains and if required.
- Ensure maintenance of tissue sections for further molecular testing.
- Pathologists perform microdissection, in order to ensure the highest possible amount of cancer cells, removing all other necrotic cells or normal tissue that could affect the validity of the results.
- Directly, the molecular biologist treats the tissue in a completely controlled environment with next-generation sequencing (NGS), or polymerase chain reaction of real-time (Real-time PCR) for the detection of mutations in genes of interest.
Frequently Asked Questions (FAQ)
According to the NCCN’s (National Comprehensive Cancer Network), patients with invasive ovarian cancer (serous, non-mucosal carcinomas, high-grade serious carcinoma) carrying mutations in BRCA1 & BRCA2 genes have been shown to have improved prognosis and anticipation in chemotherapy in respect of diagnosed with ovarian cancer without mutations in BRCA1 & BRCA2 genes. More specifically, these patients show:
- higher 5-year survival rates
- higher Progression-Free Survival
- better response to chemotherapy than patients with ovarian cancer without mutations in BRCA1 & BRCA2 genes
The SomArray Prostate is conducted on the biopsy material or surgical specimen (paraffin block) on which your histology examination has been conducted.
Our team will undertake the fast and safe transport of the sample to our laboratory, inform us at 2310 232 272
During your visit to our laboratory, by bank card, bank deposit, or online interbank transaction
One of the primary concerns of microDiagnostics’ Ltd is the protection of your personal data as well as the strict adherence to the conditions protecting your genetic material and medical results.
In full compliance with the General Data Protection Regulation (GDPR) we ensure that you are aware and conscious for any examination will be conducted and we do not announce results via phone calls.